Acid-Responsive Decomposable Nanomedicine Based on Zeolitic Imidazolate Frameworks for Near-Infrared Fluorescence Imaging/Chemotherapy Combined Tumor Theranostics

Heze Guo,Vincent Mukwaya,Daikun Wu,Shuhan Xiong,Hongjing Dou

DOI: https://doi.org/10.3390/pharmaceutics16060823

IF: 6.525

2024-06-19

Pharmaceutics

Abstract:Zeolitic imidazolate framework-8 (ZIF-8) nanoparticles (NPs) are gaining traction in tumor theranostics for their effectiveness in encapsulating both imaging agents and therapeutic drugs. While typically, similar hydrophilic molecules are encapsulated in either pure aqueous or organic environments, few studies have explored co-encapsulation of chemotherapeutic drugs and imaging agents with varying hydrophilicity and, consequently, constructed multifunctional ZIF-8 composite NPs for acid-responsive, near-infrared fluorescence imaging/chemotherapy combined tumor theranostics. Here, we present a one-pot method for the synthesis of uniform Cy5.5&DOX@ZIF-8 nanoparticles in mixed solvents, efficiently achieving simultaneous encapsulation of hydrophilic doxorubicin (DOX) and hydrophobic Cyanine-5.5 (Cy5.5). Surface decoration with dextran (Dex) enhanced colloidal stability and biocompatibility. The method significantly facilitated co-loading of Cy5.5 dyes and DOX drugs, endowing the composite NPs with notable fluorescent imaging capabilities and pH-responsive chemotherapy capacities. In vivo near-infrared fluorescence (NIRF) imaging in A549 tumor-bearing mice demonstrated significant accumulation of Cy5.5 at tumor sites due to enhanced permeability and retention (EPR) effects, with fluorescence intensities approximately 48-fold higher than free Cy5.5. Enhanced therapeutic efficiency was observed in composite NPs compared to free DOX, validating tumor-targeted capability. These findings suggest ZIF-8-based nanomedicines as promising platforms for multifunctional tumor theranostics.

pharmacology & pharmacy

What problem does this paper attempt to address?

This paper mainly discusses the application of zeolitic imidazole ester framework material (ZIF-8) based acid-responsive degradable nano drugs in near-infrared fluorescence imaging/chemotherapy combined tumor diagnosis and treatment. The researchers developed a one-pot synthesis method by mixing solvent (dimethyl sulfoxide/water) to simultaneously encapsulate hydrophilic and hydrophobic anti-cancer drug doxorubicin (DOX) and fluorescent dye Cy5.5, forming uniform Cy5.5&DOX@ZIF-8 nanoparticles. The surface of these particles was modified with glucosamine to enhance stability and biocompatibility.

ZIF-8 nanoparticles can effectively encapsulate drugs and imaging agents due to their biocompatibility, large surface area, and pore volume. It was found that these nanoparticles can responsively degrade and release drugs in acidic environments such as tumor microenvironments, thus achieving precise drug delivery and reducing side effects. In vivo near-infrared fluorescence imaging showed significant accumulation of Cy5.5@ZIF-8 nanoparticles at the tumor site, with fluorescence intensity approximately 48 times higher than free Cy5.5. Compared with free DOX, the nanoparticles demonstrated enhanced therapeutic effects, confirming their tumor targeting ability.

Therefore, this work proposes a novel ZIF-8-based nano drug platform for multifunctional tumor diagnosis and treatment integration, which is of great significance for the development of nano drug systems with acid responsiveness and near-infrared fluorescence imaging/chemotherapy capabilities.